Pre-transplant immunosuppression in pediatric patients undergoing haploidentical stem cell transplant for sickle cell disease is associated with positive outcomes
- 10 December 2025
- journal article
- other
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 61 (2) , 241-244
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Haploidentical Bone Marrow Transplantation for Sickle Cell DiseaseNEJM Evidence, 2025
- ASTCT Consensus Recommendations on Testing and Treatment of Patients with Donor-specific Anti-HLA AntibodiesTransplantation and Cellular Therapy, 2024
- Multi-center study on mortality in children, and adults with sickle cell anemia-risk factors and causes of deathScientific Reports, 2024
- Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell diseaseBone Marrow Transplantation, 2024
- Treatment With the Combination of Rituximab and Intravenous γ Globulin Is Effective in Promoting Engraftment in Donor-Specific Antibody Positive Patients Receiving Myeloablative Conditioning Haploidentical Stem Cell TransplantationTransplantation and Cellular Therapy, 2023
- Increased incidence of hematologic malignancies in SCD after HCT in adults with graft failure and mixed chimerismBlood, 2022
- Hematopoietic Stem Cell Transplantation for Severe Thalassemia Patients from Haploidentical Donors Using a Novel Conditioning RegimenTransplantation and Cellular Therapy, 2020
- HLA donor-specific antibodies in allogeneic hematopoietic stem cell transplantation: challenges and opportunitiesHematology-American Society Hematology Education Program, 2017
- Mortality of New York children with sickle cell disease identified through newborn screeningGenetics in Medicine, 2014
- HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell diseasePediatric Blood & Cancer, 2009